Jefferies raises peak sales estimate for Zealand Pharma obesity drug candidate
US-based investment bank Jefferies has raised its share price target for Zealand Pharma after taking a shine to one of the Danish pharmaceutical company’s obesity candidates.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.